Journal ArticleDOI
Vaccines targeting angiogenesis in melanoma
Fatemeh Zahedipour,Parvin Zamani,Khadijeh Jamialahmadi,Mahmoud Reza Jaafari,Amirhossein Sahebkar +4 more
TLDR
In this paper, a review of the potential progress in developing vaccines for targeting melanoma angiogenesis in melanoma is presented, including DNA, peptide, protein, dendritic cell-based, and endothelial cell vaccines.About:
This article is published in European Journal of Pharmacology.The article was published on 2021-12-05. It has received 3 citations till now. The article focuses on the topics: Angiogenesis & Melanoma.read more
Citations
More filters
Journal ArticleDOI
Statins and angiogenesis in non-cardiovascular diseases.
TL;DR: Statins inhibit HMG-CoA reductase by competitively inhibiting the active site of the enzyme, thus preventing cholesterol synthesis and reducing the risk of developing cardiovascular disease as mentioned in this paper .
Journal ArticleDOI
Application of VEGF/VEGFR peptide vaccines in cancer: a systematic review of clinical trials.
Fatemeh Zahedipour,Seyede Atefe Hosseini,Mojgan Astaneh,Prashant Kesharwani,Mahmoud Reza Jaafari,Amirhossein Sahebkar +5 more
TL;DR: In this article , a systematic review was conducted to provide a comprehensive evaluation of the therapeutic efficacy, immune response, survival rate, and side effects of VEGF/VEGF receptor-based peptide vaccines.
Journal ArticleDOI
Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma
Fatemeh Zahedipour,Parvin Zamani,Mohammad Mashreghi,Mojgan Astaneh,Mojtaba Sankian,Atefeh Amiri,Khadijeh Jamialahmadi,Mahmoud Reza Jaafari +7 more
TL;DR: In this article , the VEGFR-2-derived peptides were restricted to both mouse MHC I and human HLA-A* using immunoinformatic tools and selected three peptides representing the highest binding affinities.
References
More filters
Journal ArticleDOI
Dendritic cells and the control of immunity
TL;DR: Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow molecular and cell biological analysis and the realization that these cells are a powerful tool for manipulating the immune system is realized.
Journal ArticleDOI
Recent advances with liposomes as pharmaceutical carriers.
TL;DR: For further successful development of this field, promising trends must be identified and exploited, albeit with a clear understanding of the limitations of these approaches.
Journal ArticleDOI
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet,Rakesh K. Jain +1 more
TL;DR: Preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Journal ArticleDOI
Mechanisms of angiogenesis and arteriogenesis.
TL;DR: The cellular and molecular mechanisms underlying the formation of endothelium-lined channels and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiological and pathological conditions are summarized, alongside with possible therapeutic applications.
Journal ArticleDOI
Vascular endothelial growth factor: basic science and clinical progress.
TL;DR: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and an angiogenic inducer in a variety of in vivo models and is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration.